ABSTRACT
The sobering statistics for ruptured aneurysm emphasize the importance of rigorous screening programs for patients at risk for degenerative and hereditary aneurysms. Such programs may translate into decreased incidence of rupture and improved survival (3,4). Understanding the inheritance patterns and the molecular biology (5) of this disease will be imperative for the development of genetic and pharmacologic interventions to slow the progression to rupture.
